Tag: 2

Type 2 diabetes: Sexual orientation may influence risk

The National Institutes of Health (NIH) estimate that more than 30 million people in the United States live with type 2 diabetes. Many of the risk factors for diabetes are lifestyle habits that can be changed. Being physically active, eating right, and trying to maintain a healthy weight can all lower the risk. Some other

This SI Swim Model Shared a Powerful Post About Going From a Size 2 to a Size 8 and Overcoming Her Eating Disorder

Mia Kang doesn’t hold back. The former Sports Illustrated swimsuit model and professional Muay Thai fighter has been open about her past struggles with anorexia and bulimia. Just last year, Kang told Health that she had previously binged and purged and also abused laxatives as a young model striving for the “perfect” body.  All that changed when she discovered Muay

First results announced for the AVIATOR 2 international multicenter registry

Results of the AVIATOR 2 international registry are being presented as late-breaking clinical science at the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions. The AVIATOR 2 is a multicenter prospective observational study of patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) in 11 international sites. The use of a novel

Evening preference linked to higher BMI in type 2 diabetes

(HealthDay)—Evening preference and a later breakfast are associated with elevated body mass index (BMI) in adults with type 2 diabetes, according to a study published online April 13 in Diabetic Medicine. Hataikarn Nimitphong, M.D., from Mahidol University in Bangkok, and colleagues examined the correlations among meal timing, morning-evening preference, and BMI in 210 non-shift workers

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. The research, led by scientists from Imperial College London and published in the Journal of the American Medical Association, studied three types of diabetes treatment: sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like